InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.555

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$192 Notification regarding unquoted securities - ARX 5 Jan 2023 10:32AM $1.130 $0.555 fallen by 50.88%
$192 Change of Director's Interest Notice - JD 16 Dec 2022 10:20AM $1.055 $0.555 fallen by 47.39%
$192 Notification regarding unquoted securities - ARX 16 Dec 2022 10:17AM $1.055 $0.555 fallen by 47.39%
$192 Section 708A Notice 16 Dec 2022 10:16AM $1.055 $0.555 fallen by 47.39%
$192 Application for quotation of securities - ARX 16 Dec 2022 10:15AM $1.055 $0.555 fallen by 47.39%
$192 Notification regarding unquoted securities - ARX 12 Dec 2022 10:57AM $1.080 $0.555 fallen by 48.61%
$192 Aroa Half Year Results Presentation 29 Nov 2022 10:56AM $1.075 $0.555 fallen by 48.37%
$192 Aroa Biosurgery Half Yearly Results H1 FY23 29 Nov 2022 9:14AM $1.055 $0.555 fallen by 47.39%
$192 Appendix 4D and Half Year Report 29 Nov 2022 9:09AM $1.055 $0.555 fallen by 47.39%
$192 Notification regarding unquoted securities - ARX 28 Nov 2022 2:23PM $1.070 $0.555 fallen by 48.13%
$192 Appendix 3G 28 Nov 2022 2:23PM $1.070 $0.555 fallen by 48.13%
$192 Notification of Half Year Results Webinar 23 Nov 2022 9:34AM $1.050 $0.555 fallen by 47.14%
$192 Initial Director's Interest Notice - CM 8 Nov 2022 1:52PM $0.850 $0.555 fallen by 34.71%
$192 Change of Registry Address 31 Oct 2022 4:04PM $0.853 $0.555 fallen by 34.90%
$192 Becoming a substantial holder 26 Oct 2022 1:19PM $0.870 $0.555 fallen by 36.21%
$192 Investor Presentation 25 Oct 2022 12:58PM $0.850 $0.555 fallen by 34.71%
$192 September 2022 Quarterly Report and Appendix 4C 25 Oct 2022 9:51AM $0.805 $0.555 fallen by 31.06%
$192 Notification of Quarterly Webinar 19 Oct 2022 9:04AM $0.795 $0.555 fallen by 30.19%
$192 Pre-Clinical Study of Enivo Shows Potential 18 Oct 2022 9:51AM $0.790 $0.555 fallen by 29.75%
$192 Notification of cessation of securities - ARX 12 Oct 2022 1:06PM $0.765 $0.555 fallen by 27.45%
$192 Dr Catherine Mohr to join Aroa Board 13 Sep 2022 9:38AM $0.775 $0.555 fallen by 28.39%
$192 Change of Director's Interest Notice - JD 2 Sep 2022 9:10AM $0.775 $0.555 fallen by 28.39%
$192 Results of Annual General Meeting 10 Aug 2022 5:16PM $0.830 $0.555 fallen by 33.13%
$192 CEO Presentation - AGM 10 Aug 2022 10:56AM $0.850 $0.555 fallen by 34.71%
$192 Chairman's Address - AGM 10 Aug 2022 10:52AM $0.850 $0.555 fallen by 34.71%

201 - 225 of 765 results

Page 9 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.